• 1
    Ashley CT Jr, Warren ST. Trinucleotide repeat expansion and human disease. Annu Rev Genet 1995;29: 70328.
  • 2
    Atkin NB. Microsatellite instability. Cytogenet Cell Genet 2001;92: 17781.
  • 3
    Murty VV, Li RG, Mathew S, Reuter VE, Bronson DL, Bosl GJ, Chaganti RS. Replication error-type genetic instability at 1q42–43 in human male germ-cell tumors. Cancer Res 1994;54: 393885.
  • 4
    Huddart RA, Wooster R, Horwich A, Cooper CS. Microsatellite instability in human testicular germ cell tumors. Br J Cancer 1995;72: 6425.
  • 5
    Faulkner SW, Friedlander ML. Microsatellite instability in germ cell tumors of the testis and ovary. Gynecol Oncol 2000;79: 3843.
  • 6
    King BL, Peng H-Q, Goss P, Huan S, Bronson D, Kacinski M, Hogg D. Repeat expansion detection analysis of (CAG)n tracts in tumor cell lines, testicular tumors and testicular cancer families. Cancer Res 1997;57: 20914.
  • 7
    Teh BT, Linblad K, Nord B, Kytola S, Schalling M, Larsson C, Rapley E, Biggs P, Huddart R, Stratton M. Familial testicular cancer: lack of evidence for trinucleotide repeat expansions and association with PKD1 in one family. J Med Genet 1999;36: 3489.
  • 8
    Ono Y, Rajpert-De Meyts E, Guellaën G, Bulle F. Sporadic testicular germ cell cancers do not exhibit specific alteration in CAG/CTG repeats containing genes expressed in human testis. Oncogene 2001;50: 554853.
  • 9
    Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical and molecular perspectives. Endocr Rev 1995;16: 271321.
  • 10
    Hiort O, Holterhus P-M, Nitsche EM. Physiology and pathophysiology of androgen action. Baillière's Clin Endocrinol Metab 1998;12: 11532.
  • 11
    Sultan C, Paris F, Terouanne B, Balaguer P, Georget V, Poujol N, Jeandel C, Lumbroso S, Nicolas J-C. Disorders linked to insufficient androgen action in male children. Hum Reprod Update 2001;7: 31422.
  • 12
    Savage MO, Lowe DG. Gonadal neoplasia and abnormal sexual differentiation. Clin Endocrinol 1990;32: 51933.
  • 13
    Skakkebæk NE, Berthelsen JG, Giwercman A, Müller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumors except spermatocytoma. Int J Androl 1987;10: 1928.
  • 14
    Ulbright TM, Amin MB, Young RH. Tumors of the testis, adnexa, spermatic cord and scrotum. In: RosaiJ, ed. Atlas of tumor pathology. Third series, Fascicle 25. Washington, DC: Armed Forces Institute of Pathology, 1999, 385 p.
  • 15
    Rajpert-De Meyts E, Jørgensen NE, Nielsen KB, Müller J, Skakkebæk NE. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS 1998;106: 198206.
  • 16
    Rajpert-De Meyts E, Skakkebæk NE. The possible role of sex hormones in the development of testicular cancer. Eur Urol 1993;23: 549.
  • 17
    Skakkebæk NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001;16: 9728.
  • 18
    Edwards A, Hammond HA, Jin L, Caskey T, Chakraborty R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 1992;12: 24153.
  • 19
    Kuhlenbaumer G, Kress W, Ringelstein EB, Stogbauer F. Thirty-seven CAG repeats in the androgen receptor gene in two healthy individuals. J Neurol 2001;248: 236.
  • 20
    Arbizu T, Santamaria J, Gomez JM, Quilez A, Serra JP. A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure. J Neurol Sci 1983;59: 37182.
  • 21
    La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352: 779.
  • 22
    Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acid Res 1994;22: 31816.
  • 23
    Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Yong EL. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production and male infertility. J Clin Endocrinol Metab 1997;82: 377782.
  • 24
    Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, Coetzee GA. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet 2000;9: 26774.
  • 25
    Choong CS, Kemppainen JA, Zhou Z-X, Wilson EM. Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol 1996;10: 152735.
  • 26
    Lim HN, Nixon RM, Chen H, Hughes IA, Hawkins JR. Evidence that longer androgen receptor polyglutamine repeats are a causal factor for genital abnormalities. J Clin Endocrinol Metab 2001;86: 320710.
  • 27
    Puscheck EE, Behzadian MA, McDonough PG. The first analysis of exon 1 (transactivation domain) of the androgen receptor gene in infertile men with oligospermia or azoospermia. Fertil Steril 1994;62: 10358.
  • 28
    Mifsud A, Sim CKS, Boettger-Tong S, Moreira S, Lamb DJ, Lipshultz LI, Yong EL. Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: molecular markers of risk for male infertility. Fertil Steril 2001;75: 27581.
  • 29
    Lundberg Giwercman Y, Xu C, Arver S, Pousette Å, Reneland R, Lithell H, Wedell A. No association between the androgen receptor gene CAG repeat and impaired sperm production in Swedish men. Clin Genet 1998;54: 4356.
  • 30
    Muroya K, Sasagawa I, Suzuki Y, Nakada T, Ishii T, Ogata T. Hypospadias and the androgen receptor gene: mutation screening and CAG repeat length analysis. Mol Hum Reprod 2001;7: 40913.
  • 31
    Rajpert-De Meyts E, Leffers H, Petersen HJ Andersen A-G, Carlsen E, Jørgensen N, Skakkebæk NE. The CAG repeat length in the androgen receptor gene and reproductive variables in fertile and infertile men. Lancet 2002;359: 446.
  • 32
    Van Golde R, Van Houwelingen K, Kiemeney L, Kremer J, Tuerlings J, Schalken J, Meuleman E. Is increased CAG repeat length in the androgen receptor gene a risk factor for male subfertility? J Urol 2002;167: 6213.
  • 33
    Jørgensen N Andersen A-G, Eustache F, Irvine DS, Suominen J, Petersen JH Andersen AN, Auger J, Cawood E, Horte A, Jensen TK, Jouannet P, Keiding N, Vierula M, Toppari J, Skakkebæk NE. Regional differences in semen quality in Europe. Hum Reprod 2001;16: 10129.
  • 34
    Jørgensen M, Bévort M, Kledal TS, Hansen BV, Dalgaard M, Leffers H. Differential display competitive PCR: an optimal tool for assaying gene expression. Electrophoresis 1999;51: 23040.
  • 35
    Legius E, Vanderschueren D, Spiessens C, D'Hooghe T, Matthijs G. Association between CAG repeat number in the androgen receptor and male infertility in a Belgian study. Clin Genet 1999;56: 1667.
  • 36
    Møller H. Trends in incidence of testicular cancer and prostate cancer in Denmark. Hum Reprod 2001;16: 100711.
  • 37
    Petersen PM, Skakkebæk NE, Vistisen K, Rørth M, Giwercman A. Semen quality and reproductive hormones before orchidectomy in men with testicular cancer J Clin Oncol 1999;17: 9417.
  • 38
    Møller H, Skakkebæk NE. Risk of testicular cancer in subfertile men: case-control study. Br Med J 1999;318: 55962.
  • 39
    Jacobsen R, Bostofte E, Engholm G, Hansen J, Skakkebæk NE, Møller H. Fertility and offspring sex ratio of men who develop testicular cancer: a record linkage study. Hum Reprod 2000;15: 195861.
  • 40
    Jacobsen R, Bostofte E, Engholm G, Hansen J, Olsen JH, Skakkebæk NE, Møller H. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. Br Med J 2000;321: 78992.
  • 41
    Von Eckardstein S, Syska A, Gromoll J, Kamischke A, Simoni M, Nieschlag E. Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J Clin Endocrinol Metab 2001;86: 258590.
  • 42
    Nelson KA, Witte JS. Androgen receptor CAG repeats and prostate cancer. Am J Epidemiol 2002;155: 88390.